Sinyoo Information Technology (Shanghai) Co., Ltd.

Sinyoo Information Technology (Shanghai) Co., Ltd. was founded in 2013 with a clear focus on providing highly effective clinical research and patient management solutions for oncologists. The company's data platform crabyter®科研宝 enables oncologists to conveniently store structured and machine-readable medical data, facilitating easy access to crucial information such as diagnosis, treatment, examination data, genetic information, and patient feedback. With a CNY20.00M Series B investment at 07 December 2016 from Kaitai Capital, Proxima Ventures, Sinyoo has demonstrated its potential in the market.

Sinyoo currently boasts over 100 staff across 3 offices in Shanghai, Beijing, and Guangzhou, and has expanded its business coverage to 19 provinces in China. The company has established partnerships with over 300 Grade-A hospitals and 900 oncology departments, with 8000 oncologists utilizing the system and accumulating over 300,000 research cases. Notably, Sinyoo is a member of the China Society of Clinical Oncology (CSCO), a strategic partner of the China Anti-Cancer Association (CACA), and a gold member of the Clinical Data Interchange Standards Consortium (CDISC).

As the sole data platform for the "China Gastrointestinal Tumor Surgery Alliance," Sinyoo provides comprehensive data quality control, controlled data sharing, and efficient data mining and analysis services, emphasizing its commitment to contributing to the development of China's oncology industry. With its bold vision of "集数据之力、造医患之福" (Harnessing the power of data to benefit patient and medical outcomes), Sinyoo is poised to make a significant impact in the field of oncology research and data management.